All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
HTGM / HTG Molecular Diagnostics Inc
|
|
|
|
|
|
|
|
ZYNE / Zynerba Pharmaceuticals Inc
|
|
|
|
|
|
|
|
TSRO / TESARO, Inc.
|
|
|
|
|
|
|
|
NVAX / Novavax, Inc.
|
|
|
|
|
|
|
|
US62857M1053 / MyoKardia, Inc.
|
|
|
|
|
|
|
|
MTEM / Molecular Templates, Inc.
|
|
|
|
|
|
|
|
YMTX / Yumanity Therapeutics Inc
|
|
|
|
|
|
|
|
KITE / Kite Pharma, Inc.
|
|
|
|
|
|
|
|
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
REPH / Societal CDMO Inc
|
|
|
|
|
|
|
|
NKTR / Nektar Therapeutics
|
|
|
|
|
|
|
|
NERV / Minerva Neurosciences, Inc.
|
|
|
|
|
|
|
|
CLRBW / Cellectar Biosciences, Inc. Warrants expiring 8/20/2019
|
|
|
|
|
|
|
|
ONSIZ / Oncobiologics, Inc. Series B Warrant Expiring 5/18
|
|
|
|
|
|
|
|
CRVS / Corvus Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
RGLS / Regulus Therapeutics Inc.
|
|
|
|
|
|
|
|
ALDR / Alder BioPharmaceuticals, Inc.
|
|
|
|
|
|
|
|
EPRSQ / Epirus Biopharmaceuticals Inc
|
|
|
|
|
|
|
|
SYNH / Syneos Health Inc - Class A
|
|
|
|
|
|
|
|
AGIO / Agios Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
IMDZ / Immune Design Corp.
|
|
|
|
|
|
|
|
ADXS / Ayala Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
88165UAB5 / TetraLogic Pharmaceuticals Corporation Bond
|
|
|
|
|
|
|
|
ONSIW / Oncobiologics, Inc. Series A Warrant Expiring 2/18/2018
|
|
|
|
|
|
|
|
US7170711045 / Pfenex Inc.
|
|
|
|
|
|
|
|
RARE / Ultragenyx Pharmaceutical Inc.
|
|
|
|
|
|
|
|
AGRX / Agile Therapeutics, Inc.
|
|
|
|
|
|
|
|
NSTG / NanoString Technologies, Inc.
|
|
|
|
|
|
|
|
EPZM / Epizyme Inc
|
|
|
|
|
|
|
|
SGMO / Sangamo Therapeutics, Inc.
|
|
|
|
|
|
|
|
09074D103 / Biotie Therapies Corp.
|
|
|
|
|
|
|
|
AGTC / Applied Genetic Technologies Corp
|
|
|
|
|
|
|
|
US64052L1061 / Neos Therapeutics, Inc.
|
|
|
|
|
|
|
|
IOVA / Iovance Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
PVCT / Provectus Biopharmaceuticals, Inc.
|
|
|
|
|
|
|
|
FWP / Forward Pharma A/S - ADR
|
|
|
|
|
|
|
|
US00448Q2012 / Achillion Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
SRRA / Sierra Oncology Inc
|
|
|
|
|
|
|
|
IL0011177958 / Intec Pharma Ltd
|
|
|
|
|
|
|
|
NVRO / Nevro Corp.
|
|
|
|
|
|
|
|
PVCT / Provectus Biopharmaceuticals, Inc.
|
|
|
|
|
|
|
|
RLYP / Relypsa, Inc.
|
|
|
|
|
|
|
|
DVAX / Dynavax Technologies Corporation
|
|
|
|
|
|
|
|
CLLS / Cellectis S.A. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
NLTX / Neoleukin Therapeutics, Inc.
|
|
|
|
|
|
|
|
MGNX / MacroGenics, Inc.
|
|
|
|
|
|
|
|
GNVC / GenVec, Inc.
|
|
|
|
|
|
|
|
CYAD / Celyad Oncology - ADR
|
|
|
|
|
|
|
|
RGNX / REGENXBIO Inc.
|
|
|
|
|
|
|
|
ACRS / Aclaris Therapeutics, Inc.
|
|
|
|
|
|
|
|
PATI / Patriot Transportation Holding, Inc.
|
|
|
|
|
|
|
|
FOLD / Amicus Therapeutics, Inc.
|
|
|
|
|
|
|
|
RMTI / Rockwell Medical, Inc.
|
|
|
|
|
|
|
|
VTAE / Vitae Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
QTNT / Quotient Ltd
|
|
|
|
|
|
|
|
VCYT / Veracyte, Inc.
|
|
|
|
|
|
|
|
DERM / Journey Medical Corporation
|
|
|
|
|
|
|
|
TPST / Tempest Therapeutics, Inc.
|
|
|
|
|
|
|
|
MCRB / Seres Therapeutics, Inc.
|
|
|
|
|
|
|
|
CELG / Celgene Corp.
|
|
|
|
|
|
|
|
CFRX / ContraFect Corp
|
|
|
|
|
|
|
|
DXCM / DexCom, Inc.
|
|
|
|
|
|
|
|
ALNY / Alnylam Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
0PP / Portola Pharmaceuticals Inc
|
|
|
|
|
|
|
|
CBPO / China Biologic Products Holdings Inc
|
|
|
|
|
|
|
|
OTLK / Outlook Therapeutics, Inc.
|
|
|
|
|
|
|
|
BCRX / BioCryst Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
BLCM / Bellicum Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
CLSD / Clearside Biomedical, Inc.
|
|
|
|
|
|
|
|
SRNE / Sorrento Therapeutics, Inc.
|
|
|
|
|
|
|
|
CRBP / Corbus Pharmaceuticals Holdings, Inc.
|
|
|
|
|
|
|
|
15117F112 / Cellectar Biosciences, Inc. Series A Warrants
|
|
|
|
|
|
|
|
TBPH / Theravance Biopharma, Inc.
|
|
|
|
|
|
|
|
IVTY / Invuity, Inc.
|
|
|
|
|
|
|
|
COLL / Collegium Pharmaceutical, Inc.
|
|
|
|
|
|
|
|
ATRA / Atara Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
CTMX / CytomX Therapeutics, Inc.
|
|
|
|
|
|
|
|
OMER / Omeros Corporation
|
|
|
|
|
|
|
|
GLYC / GlycoMimetics, Inc.
|
|
|
|
|
|
|
|
AGEN / Agenus Inc.
|
|
|
|
|
|
|
|
APTO / Aptose Biosciences Inc.
|
|
|
|
|
|
|
|
CHRS / Coherus Oncology, Inc.
|
|
|
|
|
|
|
|
MRTX / Mirati Therapeutics, Inc.
|
|
|
|
|
|
|
|
AVEO / AVEO Pharmaceuticals Inc
|
|
|
|
|
|
|
|
ARDX / Ardelyx, Inc.
|
|
|
|
|
|
|
|
XLRN / Acceleron Pharma Inc
|
|
|
|
|
|
|
|
CLRB / Cellectar Biosciences, Inc.
|
|
|
|
|
|
|
|
CRIS / Curis, Inc.
|
|
|
|
|
|
|
|
WVE / Wave Life Sciences Ltd.
|
|
|
|
|
|
|
|
SNDX / Syndax Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
HRTX / Heron Therapeutics, Inc.
|
|
|
|
|
|
|
|
BPMC / Blueprint Medicines Corporation
|
|
|
|
|
|
|
|
SAGE / Sage Therapeutics, Inc.
|
|
|
|
|
|
|
|
EGRX / Eagle Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
ALKS / Alkermes plc
|
|
|
|
|
|
|
|
NBIX / Neurocrine Biosciences, Inc.
|
|
|
|
|
|
|
|
LPCN / Lipocine Inc.
|
|
|
|
|
|
|
|